News
-
-
PRESS RELEASE
Prodware: Phast Invest announces its intention to file a public buy-out offer, followed by a squeeze-out for Prodware shares at €28 per share
Phast Invest to file public buy-out offer for Prodware shares at €28/share, followed by squeeze-out. Offer at premium of 147.8% on previous day's closing price -
-
-
-
-
-
-
PRESS RELEASE
THX Pharma announces the launch of a capital increase with preferential subscription rights of nearly EUR 8 million
THX Pharma launches a €8 million capital increase to fund rare neurological drug development, with 75.5% commitments secured. Batten-1 and TX01 to lead clinical and commercial endeavors with strategic shift to international markets. Investment opportunities for various tax schemes -